Senolytics—a class of drugs that reduce chronic inflammation and tissue damage in aging cells—are shown to eliminate 30% to 70% of "zombie" cells in the body. These zombie cells, known as senescent ...
Despite all the research happening around understanding Alzheimer’s disease in the past few decades, the reality is that scientists still don’t have great answers for struggling patients. This has led ...
A new pilot study known as STAMINA (Senolytics To Alleviate Mobility Issues and Neurological Impairments in Aging), that focused on the effects of senolytic medications, Dasatinib and Quercetin (DQ), ...
A new research paper was published in Aging (Aging-US) on March 29, 2025, as the cover of Volume 17, Issue 3, titled "Differential senolytic inhibition of normal versus Aβ-associated cholinesterases: ...
A new pilot study known as STAMINA (Senolytics To Alleviate Mobility Issues and Neurological Impairments in Aging), that ...
In a sterile laboratory, researchers examine petri dishes containing what could be the key to extending human lifespan. These aren’t experimental stem cells or gene therapies, but rather compounds ...
“This work provides new opportunities for the development of the next generation of ChE inhibitors that specifically target AChE and BChE associated with AD pathology.” “This work provides new ...
Hebrew SeniorLife Hinda and Arthur Marcus Institute for Aging Research A new pilot study known as STAMINA (Senolytics To Alleviate Mobility Issues and Neurological Impairments in Aging), that focused ...
ROCHESTER, Minn. — The presence of senescent or dysfunctional cells can make young mice age faster. And using senolytic drugs in elderly mice to remove these rogue cells can improve health and extend ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Finding new drugs—called "drug discovery"—is an expensive and time-consuming task. But a type of artificial intelligence called machine learning can massively accelerate the process and do the job for ...
Despite all the research happening around understanding Alzheimer’s disease in the past few decades, the reality is that scientists still don’t have great answers for struggling patients. This has led ...